What is the current Price Target for the Kura Oncology, Inc. stock?

The average Kura Oncology, Inc. target price is $27.75. This is 262.75% higher than the current stock price. The highest price target is 422.88%, the lowest is 30.72%. 12 Analysts have issued a price target Kura Oncology, Inc. 2026 .

How high will the Kura Oncology, Inc. stock rise?

No reliable answer can be given as to how high the Kura Oncology, Inc. stock will rise. The performance of stocks, including the Kura Oncology, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Kura Oncology, Inc. stock today?

The performance of Kura Oncology, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Kura Oncology, Inc. stock fall?

The decline in Kura Oncology, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Kura Oncology, Inc. Forecast, price target & analysts

$7.39

3.46% today

Nasdaq, Feb 28, 08:16 pm CET

ISIN

US50127T1097

Symbol

KURA

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Kura Oncology, Inc. Target price 2025 - Analyst rating & recommendation

Kura Oncology, Inc. Classifications & Recommendation:

Buy

80%

Hold

20%

Kura Oncology, Inc. Price Target

Target Price	$27.75
Price	$7.65
Potential	262.75% register free of charge
Number of Estimates	12

	12 Analysts have issued a price target Kura Oncology, Inc. 2026 . The average Kura Oncology, Inc. target price is $27.75. This is 262.75% register free of charge higher than the current stock price. The highest price target is $40.00 422.88% register free of charge , the lowest is $10.00 30.72% register free of charge .
	A rating was issued by 15 analysts: 12 Analysts recommend Kura Oncology, Inc. to buy, 3 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Kura Oncology, Inc. stock has an average upside potential 2026 of 262.75% register free of charge . Most analysts recommend the Kura Oncology, Inc. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '23	2024 Estimates
Earnings Per Share $	-2.08	-2.45
	2.46%	17.79%
P/E		negative

11 Analysts have issued a Kura Oncology, Inc. forecast for earnings per share. The average Kura Oncology, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2023	$-2.08	2.46%
2024	$-2.45 17.79% Unlock
2025	$-1.74 28.98% Unlock
2026	$-1.58 9.20% Unlock
2027	$-1.55 1.90% Unlock
2028	$-0.30 80.65% Unlock
2029	$1.99 763.33% Unlock

Current	-3.78	62.31%
2024	-3.22 14.81% Unlock
2025	-4.40 36.65% Unlock
2026	-4.85 10.23% Unlock
2027	-4.95 2.06% Unlock
2028	-25.62 417.58% Unlock
2029	3.85 115.03% Unlock

Kura Oncology, Inc....

Current Kura Oncology, Inc. Upgrades & Downgrades Beta

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
HC Wainwright & Co.	Locked ➜ Locked	Locked	Feb 27 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Feb 06 2025
JMP Securities	Locked ➜ Locked	Locked	Feb 06 2025
Wedbush	Locked ➜ Locked	Locked	Feb 06 2025
Scotiabank	Locked ➜ Locked	Locked	Jan 08 2025
Cantor Fitzgerald	Locked ➜ Locked	Locked	Dec 09 2024
Cantor Fitzgerald	Locked ➜ Locked	Locked	Nov 26 2024

Analyst Rating	Date
Locked HC Wainwright & Co.: Locked ➜ Locked	Feb 27 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Feb 06 2025
Locked JMP Securities: Locked ➜ Locked	Feb 06 2025
Locked Wedbush: Locked ➜ Locked	Feb 06 2025
Locked Scotiabank: Locked ➜ Locked	Jan 08 2025
Locked Cantor Fitzgerald: Locked ➜ Locked	Dec 09 2024
Locked Cantor Fitzgerald: Locked ➜ Locked	Nov 26 2024

Discover more stocks with a high price target

Coinbase Global, Inc. 60.51%

BioNTech SE - ADR 30.07%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now